Cardiac magnetic resonance in adults with congenital heart disease.

about

Cardiac magnetic resonance in adults with congenital heart disease.

Item

http://www.wikidata.org/entity/Q38143060

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Cardiac magnetic resonance in adults with congenital heart disease.

@en

type

Item

label

Cardiac magnetic resonance in adults with congenital heart disease.

@en

prefLabel

Cardiac magnetic resonance in adults with congenital heart disease.

@en

P1476

Cardiac magnetic resonance in adults with congenital heart disease

@en

P2093

Anne Marie Valente

http://www.w3.org/2001/XMLSchema#string

Sara L Partington

http://www.w3.org/2001/XMLSchema#string

P2860

Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support.

Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology.

Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries.

Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia.

Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot.

Long-term predictors of aortic root dilation and aortic regurgitation after arterial switch operation.

Transposition of the great arteries.

Reproducibility of MRI measurements of right ventricular size and function in patients with normal and dilated ventricles.

Cardiovascular applications of phase-contrast MRI.

Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome.

P304

156-162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14797/MDCJ-9-3-156

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24066199

http://www.w3.org/2001/XMLSchema#string

P921

birth defect

P932

3782323

http://www.w3.org/2001/XMLSchema#string